- Home
- MRSN vs SACH Comparison
MRSN vs SACH Comparison
Compare MRSN & SACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRSN | SACH |
|---|---|---|
| Founded | 2001 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 138.8M | 52.0M |
| IPO Year | 2017 | 2017 |
Fundamental Metrics
Financial Performance| Metric | MRSN | SACH |
|---|---|---|
| Price | $27.78 | $1.09 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 3 |
| Target Price | ★ $30.38 | $2.00 |
| AVG Volume (30 Days) | ★ 237.3K | 181.0K |
| Earning Date | 11-14-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 18.35% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $33,180,000.00 | $3,906,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.73 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $5.21 | $0.80 |
| 52 Week High | $70.73 | $1.48 |
Technical Indicators
Market Signals| Indicator | MRSN | SACH |
|---|---|---|
| Relative Strength Index (RSI) | 83.68 | 57.96 |
| Support Level | $27.31 | $1.00 |
| Resistance Level | $28.36 | $1.08 |
| Average True Range (ATR) | 0.52 | 0.05 |
| MACD | -0.26 | 0.01 |
| Stochastic Oscillator | 51.65 | 72.22 |
Price Performance
Historical ComparisonAbout MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.
About SACH Sachem Capital Corp.
Sachem Capital Corp is a real estate investment trust. The company specializes in originating, underwriting, funding, servicing, and managing a portfolio of short-term loans secured by first mortgage liens on real property located in Connecticut. Its primary objective is to grow the loan portfolio while protecting and preserving capital in a manner that provides for attractive risk-adjusted returns to shareholders over the long term through dividends. The company earns majority of its revenue through Interest income from loans.